FDA approval for preloaded capsular tension ring
OPHTEC USA has received FDA approval for its RingJect design changes
Colin Kerr
Published: Saturday, June 1, 2019
OPHTEC USA has received FDA approval for the RingJect™ delivery system design optimisation changes.
The OPHTEC CTR is made of PMMA with patented compression moulding technology, making for
a durable, flexible device to stabilise the capsular bag in the presence of weakened or compromised zonules.
Abraham Farhan, Vice President and General Manager of OPHTEC USA, said: “We are grateful that the FDA has approved the Ophtec RingJect with optimised delivery system enhancements. Our surgeons and patients will continue to benefit from our legacy Capsular Tension Ring (CTR).
“We are very excited about the RingJect, as it saves time in surgery and reduces surgical preparation time.”
https://www.ophtec.com/
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.